Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- Asset Purch.
- Financing Rounds
- 1
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) General Information
Description
Worldwide distribution rights of 2 specialty drugs. The rights allows production and sale of Buccastem, used for the treatment of nausea and vomiting, and Timodine, a anti-fungal and anti-bacterial skin cream used for treating inflamed and infected skin conditions.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 103 - 105 Bath Road
- Slough SL1 3UH
- England, United Kingdom
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.
Request a free trialReckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.
Request a free trial